mild to moderate acne vulgaris. Acne vulgaris
Conditions
Interventions
Intervention 1: Intervention group: Group A azithromycin capsule 250 mg once a day for month. Intervention 2: Intervention group: Group B zinc elemental capsules 50 mg once a day for three months.
Sponsors
Tabriz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
11 Years to 30 Years
Inclusion criteria
Inclusion criteria: Patients with mild to moderate acne aged 11-30 years Patients who have more than 20 inflammatory lesions (papules and pustules) on one side of the face and no more than three nodules or cysts on the same side of the face. Not having other skin diseases involving the face Having patient satisfaction Not having other systemic diseases aggravating acne, such as Cushing's syndrome, PCO, adrenal hyperplasia, acquired and innate immune deficiency, steroid acne and acneiform rashes, etc. Patients who have not used oral or topical anti-acne drugs in the last month, including natural and UV light and herbal and traditional acne treatments.
Exclusion criteria
Exclusion criteria: Patients who use topical or systemic steroids. Patients who use anti-androgen combinations. Patients who have used oral or topical anti-acne drugs even including natural light and UV in the last month. The presence of other facial skin dermatoses and other systemic diseases that aggravate acne, such as Cushing's syndrome, PCO, adrenal hyperplasia, acquired and innate immune deficiency, steroid acne and acneiform rashes, etc. Patient dissatisfaction The presence of more than three nodules or cysts on one side of the face Patients with excoriate acne Age below 11 years and above 30 years Having an inflammatory disease on the face other than acne, such as contact, allergic or seborrheic dermatitis, etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Severity. Timepoint: Every 30 days. Method of measurement: History and clinical examination. | — |
Secondary
| Measure | Time frame |
|---|---|
| Patient satisfaction. Timepoint: every 30 days. Method of measurement: Questionnare.;Total acne lesions. Timepoint: Every 30 days. Method of measurement: clinical examination.;Index of acne severity. Timepoint: every 30 days. Method of measurement: clinical examination. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Hamide Herizchi
Tabriz University of Medical Sciences
Outcome results
None listed